Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Online First
Online First
Email alerts
Online First
July 29, 2019
Correspondence
Performance of the Systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population.
Free
Melissa G
Rodríguez-González
,
Grissell A
Valero-Gaona
,
Tania
Vargas-Aguirre
,
Luis M
Amezcua Guerra
doi:
10.1136/annrheumdis-2019-216028
July 22, 2019
Correspondence response
Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need use CRP?’ by Gonçalves
et al
Free
Leonieke J J
van Mens
,
Marleen G H
van de Sande
,
Arno W R
van Kuijk
,
Dominique
Baeten
,
Laura C
Coates
doi:
10.1136/annrheumdis-2019-215990
Correspondence
DAPSA versus cDAPSA: Do we need to use CRP?
Free
Rafaela Silva Guimarães
Gonçalves
,
Lays Miranda
de Almeida Martins
,
Henrique
de Ataide Mariz
,
Andrea Tavares
Dantas
,
Angela Luzia Branco Pinto
Duarte
doi:
10.1136/annrheumdis-2019-215960
July 15, 2019
Correspondence response
Response to: ‘Semi-quantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?’ by Cavazzana
et al
Free
Johan
Rönnelid
,
Fabricio
Espinosa-Ortega
,
Ingrid E
Lundberg
doi:
10.1136/annrheumdis-2019-215967
Correspondence
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?
Free
Ilaria
Cavazzana
,
Micaela
Fredi
,
Franco
Franceschini
doi:
10.1136/annrheumdis-2019-215884
July 13, 2019
Correspondence
Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Humby
et al
Free
Maya H
Buch
,
Andrew
Melville
,
Dennis G
McGonagle
doi:
10.1136/annrheumdis-2019-215881
Correspondence response
Response to ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Humby
et al
Free
Frances
Humby
,
Myles
Lewis
,
Michael J
Townsend
,
Costantino
Pitzalis
doi:
10.1136/annrheumdis-2019-215903
July 12, 2019
Correspondence
Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis
Free
Shih-Wei
Lai
,
Yu-Hung
Kuo
,
Kuan-Fu
Liao
doi:
10.1136/annrheumdis-2019-215982
Correspondence
Ultrasonographic salivary gland evaluation in systemic sclerosis: is sicca syndrome secondary to an authentic overlap syndrome or another specific fibrotic manifestation of the disease?
Free
Guillaume
Coiffier
,
Sandrine
Jousse-Joulin
,
Divi
Cornec
,
Ronan
Garlantézec
,
Aurore
Bleuzen
,
Elisabeth
Diot
,
Patrick
Jego
,
Alice
Ballerie
,
Alain
Lescoat
doi:
10.1136/annrheumdis-2019-215972
July 11, 2019
Correspondence
On using machine learning algorithms to define clinically meaningful patient subgroups
Free
Rachel
Knevel
,
Tom WJ
Huizinga
doi:
10.1136/annrheumdis-2019-215959
July 08, 2019
Correspondence response
Response to: ‘Achieving lupus low disease activity and remission states under belimumab in refractory systemic lupuserythematosus: time and organ involvement matter’ by Sbeih
et al
Free
Mandana
Nikpour
,
Molla
Huq
,
Shereen
Oon
doi:
10.1136/annrheumdis-2019-215922
Correspondence
Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter
Free
Nabiha
Sbeih
,
Alexis
Mathian
,
Marc
Pineton de Chambrun
,
Raphael
Lhote
,
Noël
Zahr
,
Micheline
Pha
,
Fleur
Cohen-Aubart
,
Julien
Haroche
,
Miguel
Hié
,
Sophie
Jouffroy
,
Neila
Benameur
,
Hervé
Devilliers
,
Zahir
Amoura
doi:
10.1136/annrheumdis-2019-215732
July 05, 2019
Correspondence response
Response to: ‘Less antibiotics but no inferior effect for bacterial arthritis’ by Zhang
et al
Free
Ilker
Uçkay
,
Ergys
Gjika
doi:
10.1136/annrheumdis-2019-215909
Correspondence
Is it currently reasonable to offer short, 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?
Free
Guillaume
Coiffier
,
Marion
Couderc
,
Raphaele
Seror
,
Geraldine
Bart
,
Christelle
Darrieutort-Laffite
,
Benoit
Le Goff
doi:
10.1136/annrheumdis-2019-215887
Correspondence response
Response to: ‘Is it currently reasonable to offer short 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?’ by Coiffier
et al
Free
Ilker
Uçkay
,
Amanda
Gonzalez
,
Ergys
Gjika
doi:
10.1136/annrheumdis-2019-215905
Correspondence
Less antibiotics but no inferior effect for bacterial arthritis
Free
Jian
Tian
,
Chao
Cheng
,
Fangjie
Zhang
doi:
10.1136/annrheumdis-2019-215682
July 03, 2019
Correspondence
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations
Free
Giovanni
Orsolini
,
Irene Elizabeth Maria
Bultink
,
Giovanni
Adami
,
Angelo
Fassio
,
Ombretta
Viapiana
,
Alessandro
Giollo
,
Davide
Gatti
,
Maurizio
Rossini
doi:
10.1136/annrheumdis-2019-215896
June 18, 2019
Correspondence
Association between ankylosing spondylitis and venous thromboembolism
Free
Shih-Wei
Lai
doi:
10.1136/annrheumdis-2019-215854
June 12, 2019
Correspondence
Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?
Free
Emanuel
Raschi
,
Ippazio Cosimo
Antonazzo
,
Elisabetta
Poluzzi
,
Fabrizio
De Ponti
doi:
10.1136/annrheumdis-2019-215819
May 10, 2019
Correspondence
How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials
Free
Ioannis
Parodis
,
Mandana
Nikpour
doi:
10.1136/annrheumdis-2019-215650
April 16, 2019
Correspondence
Aortic dilatation in a patient with Takayasu arteritis treated with tocilizumab
Free
Francesco
Muratore
,
Carlo
Salvarani
doi:
10.1136/annrheumdis-2019-215459
February 20, 2019
Correspondence
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester
et al
Free
Giovanni
Adami
,
Angelo
Fassio
,
Giovanni
Orsolini
,
Alessandro
Giollo
,
Davide
Gatti
,
Maurizio
Rossini
doi:
10.1136/annrheumdis-2019-215174
February 09, 2019
Correspondence
Is retinal microvascular damage an early manifestation of systemic sclerosis?
Florenzo
Iannone
,
Cinzia
Rotondo
doi:
10.1136/annrheumdis-2019-215127
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
